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Abstract
Aims Formation of a functional vascular system is essential and its formation is a highly regulated process initiated during 
embryogenesis, which continues to play important roles throughout life in both health and disease. In previous studies, Fzd5 
was shown to be critically involved in this process and here we investigated the molecular mechanism by which endothelial 
loss of this receptor attenuates angiogenesis.
Methods and results Using short interference RNA-mediated loss-of-function assays, the function and mechanism of sign-
aling via Fzd5 was studied in human endothelial cells (ECs). Our findings indicate that Fzd5 signaling promotes neoves-
sel formation in vitro in a collagen matrix-based 3D co-culture of primary vascular cells. Silencing of Fzd5 reduced EC 
proliferation, as a result of  G0/G1 cell cycle arrest, and decreased cell migration. Furthermore, Fzd5 knockdown resulted in 
enhanced expression of the factors Angpt2 and Flt1, which are mainly known for their destabilizing effects on the vasculature. 
In Fzd5-silenced ECs, Angpt2 and Flt1 upregulation was induced by enhanced PKC signaling, without the involvement of 
canonical Wnt signaling, non-canonical Wnt/Ca2+-mediated activation of NFAT, and non-canonical Wnt/PCP-mediated 
activation of JNK. We demonstrated that PKC-induced transcription of Angpt2 and Flt1 involved the transcription factor Ets1.
Conclusions The current study demonstrates a pro-angiogenic role of Fzd5, which was shown to be involved in endothelial 
tubule formation, cell cycle progression and migration, and partly does so by repression of PKC/Ets1-mediated transcription 
of Flt1 and Angpt2.
Keywords Endothelial cells · Angiogenesis · Fzd5 · Wnt signaling
Introduction
New formation of blood vessels from pre-existing vessels, a 
process called angiogenesis, is a critical step in embryogen-
esis and continues to play important roles throughout life in 
both health and disease [1]. It is a dynamic process that is 
tightly regulated by a diverse range of signal transduction 
cascades, and imbalances in these pathways can be a causa-
tive or a progressive factor in many diseases [2].
Multiple studies suggest an important role for endothelial 
signal transduction via Frizzled (Fzd) receptors in angio-
genesis [3–5]. The Fzd receptors belong to a family of 10 
transmembrane receptors (Fzd1–10), which can initiate Fzd/
Wnt canonical and non-canonical signaling upon binding 
with one of the 19 soluble Wnt ligands. Canonical Wnt sign-
aling depends on Fzd receptor and LRP 5/6 co-activation, 
initiating Disheveled (Dvl) to stabilize β-catenin, followed 
by β-catenin-mediated transcriptional regulation [6–8]. In 
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s1045 6-018-9625-6) contains 
supplementary material, which is available to authorized users.
 * Caroline Cheng 
 K.L.Cheng-2@umcutrecht.nl
1 Experimental Cardiology, Department of Cardiology, 
Thoraxcenter, Erasmus University Medical Center, 
Rotterdam, The Netherlands
2 Department of Nephrology and Hypertension, Division 
of Internal Medicine and Dermatology, University Medical 
Center Utrecht, Utrecht, The Netherlands
3 Department of Pediatric Surgery of the Erasmus 
Medical Center, Sophia Children’s Hospital, Rotterdam, 
The Netherlands
 Angiogenesis
1 3
contrast, non-canonical Wnt signaling also involves Dvl, 
but proceeds via Wnt/Ca2+-mediated activation of nuclear 
factor of activated T-cells (NFAT) or Wnt/planar cell polar-
ity (PCP)-mediated activation of c-JUN N-terminal Kinase 
(JNK) [6]. A potential link between Fzd5 and angiogenesis 
was previously demonstrated in Fzd5 full knockout mice 
[5]. Fzd5 silencing induced in utero death at approximately 
E10.5, which was associated with vascular defects in the 
placenta and yolk sac. Furthermore, isolated ECs from 
Fzd5-deficient mice showed a reduction in cell proliferation, 
which is crucial for neovessel formation. These findings sug-
gest that Fzd5 can be an important regulator of angiogenesis. 
However, the exact type of endothelial Fzd5/Wnt signaling 
and the downstream molecular mechanism causal to the poor 
vascular phenotype in the absence of this receptor requires 
further in-depth evaluation.
Here, we studied the angiogenic potential of Fzd5 and 
investigated the signaling pathways that are mediated by 
Fzd5/Wnt signaling in human ECs. Our findings indicate 
that Wnt5a, which is endogenously expressed in ECs, binds 
and signals via Fzd5, but in the absence of this receptor 
triggers a poor angiogenic phenotype via an alternative 
signaling route. We demonstrated that Fzd5 is essential for 
neovessel formation in vitro in a collagen matrix-based 3D 
co-culture of primary human vascular cells. Silencing of 
Fzd5 reduced EC proliferation as a result of  G0/G1 cell cycle 
arrest and decreased cell migration capacity. Furthermore, 
Fzd5 knockdown resulted in enhanced expression of the 
factors Angiopoietin 2 (Angpt2) and Fms-Related Tyrosine 
Kinase 1 (Flt1), which are mainly known for their destabiliz-
ing effects on the vasculature [9–11]. In Fzd5-silenced ECs, 
Angpt2 and Flt1 upregulation was induced by enhanced Pro-
tein Kinase C (PKC) signaling, without the involvement of 
canonical Wnt signaling, non-canonical Wnt/Ca2+-mediated 
activation of NFAT, and non-canonical Wnt/PCP-mediated 
activation of JNK. Further downstream, PKC-induced tran-
scription of Angpt2 and Flt1 involved the transcription factor 
Protein C-Ets-1 (Ets1), as knockdown of both Fzd5 and Ets1 
resulted in a marked repression of Angpt2 and Flt1 expres-
sion levels. In addition, silencing of Ets1 partially restored 
the impaired endothelial tubule formation capacity of Fzd5-
silenced ECs.
Methods
Cell culture
Human umbilical vein endothelial cells (HUVECs; Lonza) 
and human brain vascular pericytes (Sciencell) were cul-
tured on gelatin-coated plates in EGM2 medium (EBM2 
medium supplemented with EGM2 bullet kit; Lonza, and 
100 U/ml penicillin/streptomycin; Lonza) and DMEM 
(supplemented with 100 U/ml penicillin/streptomycin; 
Lonza, and 10% FCS; Lonza), respectively, in 5%  CO2 
at 37  °C. The experiments were performed with cells 
at passage 3–5. Lentivirus green fluorescent protein 
(GFP)-transduced HUVECs and lentivirus discosoma 
sp. red fluorescent protein (dsRED)-transduced pericytes 
were used at passages 5–7. HUVECs and GFP-labeled 
HUVECs were used from six different batches derived 
from pooled donors. Pericytes and dsRED-labeled peri-
cytes were used from eight different batches derived 
from single donors. Fzd5, Ets1, and Wnt5a knockdown 
in HUVECs was achieved by cell transfection of a pool 
containing four targeting short interference RNA (siRNA) 
sequences, whereas PKC isoforms were knocked down 
with individual siRNA strands (Dharmacon), all in a 
final concentration of 100 nM. Control cells were either 
untreated or transfected with a pool of four non-targeting 
siRNA sequences (Dharmacon) in a final concentration of 
100 nM. Target sequences are listed in Table 1. Inhibition 
of GSK3β, NFAT, JNK, and PKC activation was achieved 
with 20 µM LiCl (Sigma), 1 µM Cyclosporine A (CsA; 
Sigma), 20 µM SP600125 (Sigma), and 5, 10, and 20 nM 
staurosporine (CST), respectively. Phosphatase activity 
was inhibited with 50 nM Calyculin A. Free  Ca2+-induced 
activation of NFAT-mediated transcription was achieved 
with 10 µM A23187. In experiments involving a serum 
starvation step, the cells were cultured for 24 h in EBM2.
Table 1  siRNA sequences used in cell culture
Target gene Target sequence
Non-targeting UGG UUU ACA UGU CGA CUA A
UGG UUU ACA UGU UGU GUG A
UGG UUU ACA UGU UUU CUG A
UGG UUU ACA UGU UUU CCU A
Fzd5 GCA UUG UGG UGG CCU GCU A
GCA CAU GCC CAA CCA GUU C
AAA UCA CGG UGC CCA UGU G
GAU CCG CAU CGG CAU CUU C
Ets1 AUA GAG AGC UAC GAU AGU U
GAA AUG AUG UCU CAA GCA U
GUG AAA CCA UAU CAA GUU A
CAG AAU GAC UAC UUU GCU A
Wnt5a GCC AAG GGC UCC UAC GAG A
GUU CAG AUG UCA GAA GUA U
CAU CAA AGA AUG CCA GUA U
GAA ACU GUG CCA CUU GUA U
PKCα UAA GGA ACC ACA AGC AGU A
PKCδ CCA UGU AUC CUG AGU GGA A
PKCε GUG GAG ACC UCA UGU UUC A
PKCη GCA CCU GUG UCG UCC AUA A
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Quantitative PCR and Western blot analysis
Total RNA was isolated using RNA mini kit (Bioline) and 
reversed transcribed into cDNA using iScript cDNA syn-
thesis kit (Bioline). Gene expression was assessed by qPCR 
using SensiFast SYBR & Fluorescein kit (Bioline) and prim-
ers as listed in Table 2. Expression levels are relative to 
the housekeeping gene β-actin. For assessment of protein 
levels, cells were lysed in cold NP-40 lysis buffer (150 mM 
NaCl, 1.0% NP-40, 50 mM Tris, pH 8.0) supplemented with 
1 mM β-glycerophosphate, 1 mM PMSF, 10 mM NaF, 1 mM 
NaOV, and protease inhibitor cocktail (Roche). Total pro-
tein concentration was quantified by Pierce® BCA Protein 
Assay Kit (Thermo Scientific) as a loading control. Lysates 
were denaturated in Laemmli buffer (60 mM Tris pH 6.8, 2% 
SDS, 10% glycerol, 5% β-mercaptoethanol, 0.01% bromo-
phenol blue) at 90 °C for 5 min followed by electrophoresis 
on a 10% SDS-page gel (Biorad). Subsequently, proteins 
were transferred to a nitrocellulose membrane (Pierce) and 
incubated for 1 h in PBS with 5% non-fat milk, followed 
by incubation with rabbit anti-Fzd5 (Milipore), goat anti-
β-actin (Abcam), rabbit anti-β-catenin, anti-non-phospho 
β-catenin and phospho-β-catenin (CST, validated in Sup-
plemental Fig. 3A), rabbit anti-Angpt2 (Abcam), rabbit anti-
JNK and phospho-JNK (CST, validated in Supplemental 
Fig. 4C), rabbit anti-JUN and phospho-JUN (CST, validated 
in Supplemental Fig. 4C), rabbit anti-Wnt5a (CST) rabbit 
anti-Dvl2 (CST) according to the manufacturer’s descrip-
tion. Protein bands were visualized with the Li-Cor detec-
tion system (Westburg). Levels of secreted Flt1 in cultured 
medium were assessed 72 h post-transfection using a Flt1 
ELISA kit (R&D systems).
3D analysis of endothelial tubule formation
Twenty-four hours post siRNA transfection, GFP-labeled 
HUVECs were harvested and suspended with non-trans-
fected dsRED-labeled pericytes in collagen as previously 
described by Stratman [12]. In summary, HUVECs and 
pericytes were mixed in a 5:1 ratio in EBM2 supple-
mented with Ascorbic Acid, Fibroblast Growth Factor, 
and 2% FCS from the EGM2 bullet kit. Additionally, 
C-X-C motif chemokine 12, Interleukin 3, and Stem Cell 
Factor were added in a concentration of 800 ng/ml (R&D 
systems). The cell mixture was suspended in bovine col-
lagen (Gibco) with a final concentration of 2 mg/ml and 
pipetted in a 96-well plate. One hour of incubation in 5% 
 CO2 at 37 °C was followed by the addition of 100 µl of the 
adjusted EBM2 medium on the collagen gels. The addi-
tion of recombinant human Angpt2 and Flt1 (R&D sys-
tems) was done 24 h post seeding in the collagen matrix, 
both in a final concentration of 1000 ng/ml. Forty-eight 
hours and 120 h post seeding, these co-cultures were 
imaged by fluorescence microscopy, followed by analysis 
of the number of junctions, the number of tubules, and 
the tubule length using AngioSys. At least three technical 
replicates were averaged per condition per independent 
replicate.
Migration assay
Twenty-four hours post siRNA transfection, HUVECs 
were plated at a density of 0.5 × 105 cells/well in an Oris™ 
Universal Cell migration Assembly Kit (Platypus Tech-
nologies) derived 96-well plate with cell seeding stoppers. 
Twenty-four hours post sub-culturing, the cell stoppers were 
removed and cells were allowed to migrate into the cell free 
region for 16 h in 5%  CO2 at 37 °C. Subsequently, the cells 
were washed in PBS and stained by Calcein-AM followed 
by visualization using fluorescence microscopy. Wells in 
which cell seeding stoppers were not removed were used 
as a negative control. Results were analyzed by Clemex. At 
least three technical replicates were averaged per condition 
per independent replicate.
Intracellular immunofluorescent staining
Forty-eight hours post siRNA transfection, HUVECs were 
seeded on gelatin-coated glass coverslips in 12-well plates at 
a density of 0.5 × 105 cells/well (sub-confluent) and 3.5 × 105 
cells/well (confluent). Subsequently, cells adhered for 24 h 
followed by fixation for 15 min in 4% paraformaldehyde 
and blocking for 60 min in PBS with 5% bovine serum albu-
min (Sigma) and 0.3% Triton X-100 (Sigma). After block-
ing, coverslips were placed on droplets PBS containing 1% 
BSA, 0.3% Triton X-100, and rabbit anti-β-catenin antibody 
(CST), followed by incubation for 16 h in a humidified envi-
ronment at 4 °C. Thereafter, coverslips were incubated on 
PBS with 1% BSA and 0.3% Triton X-100 containing an 
Alexa Fluor 594-labeled secondary antibody (Invitrogen) 
and phalloidin-rhodamine (Invitrogen) for 1 h at room tem-
perature, finally followed by mounting the stained coverslips 
on vectashield with DAPI (Brunschwig). Coverslips were 
imaged by confocal microscopy.
Proliferation, cell cycle assay, and apoptosis
Twenty-four hours post siRNA transfection, HUVECs were 
seeded in six-well plates at a density of 0.5 × 105 cells/well. 
To study the effect of Fzd5 knockdown on proliferation, 
HUVECs were harvested 24, 48, and 72 h post sub-culturing 
and counted by flow cytometry. For analysis of cell cycle 
progression, cells were harvested 48 h post sub-culturing and 
fixated in 70% ethanol for 60 min on ice. Subsequently, cells 
were stained with PI and treated with RNAse (Sigma) for 
30 min at 37 °C and analyzed by flow cytometry. Apoptosis 
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Table 2  Primer sequences used 
for (q)PCR Gene Sense primer sequence Antisense primer sequence
Fzd1 GCC CTC CTA CCT CAA CTA CCA ACT GAC CAA ATG CCA ATC CA
Fzd2 GCT TCC ACC TTC TTC ACT GTC GCA GCC CTC CTT CTT GGT 
Fzd3 CTT CCC TGT CGT AGG CTG TGT GGG CTC CTT CAG TTG GTT CT
Fzd4 ATG AAC TGA CTG GCT TGT GCT TGT CTT TGT CCC ATC CTT TTG 
Fzd5 TAC CCA GCC TGT CGC TAA AC AAA ACC GTC CAA AGA TAA ACTGC 
Fzd6 GCG GAG TGA AGG AAG GAT TAG TGA ACA AGC AGA GAT GTG GAA 
Fzd7 CGC CTC TGT TCG TCT ACC TCT CTT GGT GCC GTC GTG TTT 
Fzd8 GCC TAT GGT GAG CGT GTC C CTG GCT GAA AAA GGG GTT GT
Fzd9 CTG GTG CTG GGC AGT AGT TT GCC AGA AGT CCA TGT TGA GG
Fzd10 CCT TCA TCC TCT CGG GCT TC AGG CGT TCG TAA AAG TAG CAG 
Wnt1 CAA CAG CAG TGG CCG ATG GTGG CGG CCT GCC TCG TTG TTG TGAAG 
Wnt2 GTC ATG AAC CAG GAT GGC ACA TGT GTG CAC ATC CAG AGC TTC 
Wnt2b AAG ATG GTG CCA ACT TCA CCG CTG CCT TCT TGG GGG CTT TGC 
Wnt3 GAG AGC CTC CCC GTC CAC AG CTG CCA GGA GTG TAT TCG CATC 
Wnt3a CAG GAA CTA CGT GGA GAT CATG CCA TCC CAC CAA ACT CGA TGTC 
Wnt4 GCT CTG ACA ACA TCG CCT AC CTT CTC TCC CGC ACA TCC 
Wnt5a GAC CTG GTC TAC ATC GAC CCC GCA GCA CCA GTG GAA CTT GCA 
Wnt5b TGA AGG AGA AGT ACG ACA GC CTC TTG AAC TGG TTG TAG CC
Wnt6 TTA TGG ACC CTA CCA GCA T ATG TCC TGT TGC AGG ATG 
Wnt7a GCC GTT CAC GTG GAG CCT GTG CGT GC AGC ATC CTG CCA GGG AGC CCG CAG CT
Wnt7b GAT TCG GCC GCT GGA ACT GCTC TGG CCC ACC TCG CGG AAC TTAG 
Wnt8a CTG GTC AGT GAA CAA TTT CC GTA GCA CTT CTC AGC CTG TT
Wnt8b GTC TTT TCA CCT GTG TCC TC AGG CTG CAG TTT CTA GTC AG
Wnt10a CTG TTC TTC CTA CTG CTG CT ACA CAC ACC TCC ATC TGC 
Wnt10b GCA CCA CAG CGC CAT CCT CAAG GGG GTC TCG CTC ACA GAA GTC AGG A
Wnt11 CAC TGA ACC AGA CGC AAC AC CCT CTC TCC AGG TCA AGC AAA 
Wnt14 ACA AGT ATG AGA CGG CAC TC AGA AGC TAG GCG AGT CAT C
Wnt15 TGA AAC TGC GCT ATG ACT C GTG AGT CCT CCA TGT ACA CC
Wnt16 GAG AGA TGG AAC TGC ATG AT GAT GGG GAA ATC TAG GAA CT
Axin2 TTG AAT GAA GAA GAG GAG TGGA TCG GGA AAT GAG GTA GAG ACA 
Ccnd1 GTC CAT GCG GAA GAT CGT CG TCT CCT TCA TCT TAG AGG CCACG 
C-Myc CAC AGC AAA CCT CCT CAC AG CGC CTC TTG ACA TTC TCC TC
Angpt1 GCT GAA CGG TCA CAC AGA GA CTT TCC CCC TCA AAG AAA GC
Angpt2 TTA TCA CAG CAC CAG CAA GC TTC GCG AGA ACA AAT GTG AG
VEGFa AAG GAG GAG GGC AGA ATC AT ATC TGC ATG GTG ATG TTG GA
VEGFr2 AGC GAT GGC CTC TTC TGT AA ACA CGA CTC CAT GTT GGT CA
Flt1 TGT CAA TGT GAA ACC CCA GA GTC ACA CCT TGC TCC GGA AT
DSCR1 GAG GAC GCA TTC CAA ATC AT AGT CCC AAA TGT CCT TGT GC
TF TAC TTG GCA CGG GTC TTC TC TGT CCG AGG TTT GTC TCC A
Ets1 GGA GCA GCC AGT CAT CTT TC GGT CCC GCA CAT AGT CCT T
PKCα CGA CTG GGA AAA ACT GGA GA ACT GGG GGT TGA CAT ACG AG
PKCδ ATT GCC GAC TTT GGG ATG T TGA AGA AGG GGT GGA TTT TG
PKCε AAG CCA CCC TTC AAA CCA C GGC ATC AGG TCT TCA CCA AA
PKCη TCC CAC ACA AGT TCA GCA TC CCC AAT CCC ATT TCC TTC TT
MMP1 GAT TCG GGG AGA AGT GAT GTT CGG GTA GAA GGG ATT TGT G
Β-actin TCC CTG GAG AAG AGC TAC GA AGC ACT GTG TTG GCG TAC AG
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was studied 72 h after transfection using an in situ cell death 
detection kit (Roche) as described by the manufacturer on 
4% PFA fixated cells.
Wnt5a adenovirus preparation, transduction, 
and stimulation
Recombinant adenoviruses were produced using the Gate-
way pAd/CMV/V5DEST vector and ViraPowerTM Ade-
noviral Expression System (Invitrogen), according to the 
manufacturer’s instructions. Briefly, the Wnt5a expression 
cassette was cloned from the pENTR™ 221 Wnt5a entry 
vector (Invitrogen) into pAd/CMV/V5-DEST expression 
vector (Invitrogen) via the LR-reaction II (invitrogen). After 
verification by DNA sequencing, the pAd/CMV plasmids 
were linearized by Pac1 restriction and subsequently trans-
fected with Lipofectamine 2000 (Invitrogen) in HEK293A 
cells. Infected cells were harvested by the time 80% of the 
cells detached from plates followed by isolation of viral 
particles from crude viral lysate. HeLa cells were used to 
produce Wnt5a (or dsRED, referred to as adSHAM) by 
transduction with a calculated 5 viral particles per cell. 
Forty-eight hours post-transduction, HeLa cells were cul-
tured for 24 h on EBM2, which eventually was used to stim-
ulate serum-starved endothelium for 3 h.
Statistical analysis
For each experiment, N represents the number of independ-
ent replicates. Statistical analysis was performed by Graph-
Pad Prism using one-way ANOVA followed by post hoc 
Tukey’s test, unless stated otherwise. Results are expressed 
as mean ± SEM. Significance was assigned when P < 0.05 
(two-tailed).
Results
Fzd5 siRNA induces a specific knockdown 
of endothelial Fzd5
The function of Fzd5 was studied in vitro using siRNA-
mediated silencing in HUVECs, which were shown to 
express all Fzd receptors other than Fzd10 (Supplemen-
tal Fig. 1A), and Wnt2b, 3, 4, 5a, and 11 (Supplemental 
Fig. 1B). Both qPCR and Western blot analysis confirmed 
a significant loss of Fzd5 expression in cells treated with an 
siRNA pool specific for Fzd5, compared to untreated control 
cells and cells treated with a pool of non-targeting siRNA, 
referred to as siSHAM (Supplemental Fig. 1C,D). Although 
Fzd receptors share highly similar domains, knockdown of 
Fzd5 was specific. None of the other Fzd receptors were 
differentially expressed after treatment with Fzd5 siRNA, 
other than Fzd5 (Supplemental Fig. 1C).
Wnt5a signals via endothelial Fzd5
Previous studies listed Wnt5a and Secreted Frizzled-
Related Protein 2 (SFRP2) as most likely candidates to 
activate Fzd5-mediated signaling in ECs [13–15]. In con-
trast to SFRP2 [16], Wnt5a is endogenously expressed by 
HUVECs (Supplemental Fig. 1B). To address the potential 
signal capacities of this endogenously expressed Wnt5a as 
ligand for Fzd5, HeLa cells were transduced with an adeno-
viral overexpression plasmid for Wnt5a to produce cultured 
medium containing high levels of this Wnt ligand. HeLa 
cells were selected for this purpose over HUVECs as these 
cells were shown to have a more refined machinery to pro-
duce and secrete functional Wnt5a than HUVECs, as illus-
trated by enhanced mRNA expression of Wntless (WLS) and 
Porcupine (PORCN) (data not shown). Transduction with 
this overexpression vector (adWnt5a) led to a significant 
Fig. 1  Wnt5a induced Fzd5-mediated Dvl activation in HUVECs. a 
Representative Western  blot of adenoviral-based Wnt5a overexpres-
sion in HeLa cells, 72  h post-transduction. N = 4. b Representative 
Western blot of Dvl and phosphorylated Dvl in HUVECs after 3  h 
stimulation with cultured medium (CM) from HeLa cells overex-
pressing dsRED (adSHAM) or Wnt5a, 72 h post siRNA transfection 
in HUVECs. N = 6
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upregulation of Wnt5a compared to dsRED control trans-
duced cells (adSHAM) (Fig. 1a). To assess whether Fzd5 
was involved in transducing the signal of Wnt5a, cultured 
medium from transduced HeLa cells was applied to serum-
starved HUVECs after which Dvl activation was monitored. 
Western blot analysis showed that Wnt5a strongly induced 
Dvl phosphorylation in untreated or non-targeting siRNA-
treated HUVECs, however, this effect was blocked in the 
absence of Fzd5 (Fig. 1b), confirming the importance of 
endothelial Fzd5 in transducing Wnt5a signaling.
Fzd5 expression is essential for endothelial 
proliferation, migration, and tubule formation
The angiogenic capacities of these Fzd5-silenced HUVECs 
were evaluated in a well-validated in vitro 3D angiogenesis 
assay developed for studying formation of micro-capillary 
structures [12]. In this assay, HUVECs with GFP marker 
expression and dsRED-labeled pericytes directly interact 
in a collagen type I matrix environment, resulting in EC 
sprouting, tubule formation, and neovessel stabilization as 
a result of perivascular recruitment of pericytes. At day 5 
post-seeding, well-defined, micro-capillaries with pericyte 
coverage can be observed. Imaging and quantification of the 
vascular structures were conducted at days 2 and 5. Endothe-
lial knockdown of Fzd5 strongly impaired endothelial tubule 
formation (Fig. 2a). Quantification revealed a significant 
reduction in the total tubule length, the number of endothe-
lial junctions, and the number of endothelial tubules, both 
after 2 and 5 days (Fig. 2b).
To get a better insight in the causative factor for this 
poor vascular phenotype, the migration and prolifera-
tion capacities of Fzd5-silenced ECs were studied. A 
plug-stopper-based migration assay was performed to 
analyze the effects of Fzd5 knockdown on endothelial 
mobility. Knockdown of Fzd5 significantly inhibited the 
migration of ECs towards the open cell-devoid area com-
pared to untreated and non-targeting siRNA-treated ECs 
(Fig. 3a, b). In addition, knockdown of Fzd5 significantly 
reduced cell numbers compared to control and siSHAM 
condition (Fig. 3c). To clarify whether this was a result 
of impaired cell proliferation or increased apoptosis, cell 
cycle progression was analyzed in a cell cycle assay in 
which total DNA was stained with PI, followed by flow 
cytometry. A strong increase of cells in the  G0/G1 phase 
of the cell cycle was observed after knockdown of Fzd5, 
indicative of a cell cycle arrest (Fig. 3d, e). For apoptosis 
analysis, a terminal deoxynucleotidyl transferase dUTP 
nick end labeling (TUNEL)-based detection staining was 
used. Although seeded in similar densities, Fzd5 knock-
down led to a significant reduction of nuclei per image 
field. However, the relative number of TUNEL positive 
nuclei in the Fzd5 knockdown condition was similar when 
compared to control and siSHAM condition, showing that 
the reduction of ECs in the Fzd5 knockdown condition is 
not related to increased apoptosis (Fig. 3f, g).
Loss of Fzd5 does not interfere with endogenous 
canonical Wnt signaling
To further dissect the molecular mechanism of endothelial 
Fzd5 signaling in angiogenesis, known Fzd/Wnt signaling 
pathways were studied. Downstream Fzd signaling occurs 
via the canonical Wnt signaling pathway, also known as the 
Wnt/β-catenin pathway, or by the less well described non-
canonical Wnt signaling pathways. Activation of canonical 
Wnt signaling is characterized by an accumulation of cyto-
plasmic β-catenin, eventually resulting in nuclear transloca-
tion and subsequent expression of β-catenin-dependent tar-
get genes. To evaluate the effect of Fzd5 knockdown on the 
canonical Wnt signaling pathway, total levels of β-catenin, 
as well as phospho-β-catenin (ser33/37/thr41) and non-
phospho-β-catenin (active) were examined 24, 48 and 72 h 
post-transfection by Western blot. Ser33/37/thr41 phospho-
rylation is induced by GSK3β and primes β-catenin for sub-
sequent degradation, and could be indicative for a reduced 
activity of canonical Wnt signaling. Total β-catenin, as well 
as non-phospho-β-catenin (active) levels were unaffected by 
Fzd5 silencing, and non-phospho-β-catenin (ser33/37/thr41) 
was observed in all conditions (Fig. 4a, b), even though the 
antibody was capable of detecting GSK3β-induced β-catenin 
phosphorylation (Fig. 4c). Furthermore, expression levels of 
previously described endothelial target genes of β-catenin 
were studied using qPCR, but no differences were observed 
in the expression of Axin2, Ccnd1, and C-myc after knock-
down of Fzd5 (Fig. 4d). An immunofluorescent staining, 
validated to detect cellular distribution of β-catenin (Supple-
mental Fig. 3B), was also performed on transfected ECs, as 
stable total levels of β-catenin found by Western blot did not 
deviate between cytoplasmic or nuclear localized β-catenin. 
In line with the other experiments focusing on β-catenin-
mediated signaling, no differences in β-catenin localization 
were observed after knockdown of Fzd5, both in confluent 
and sub-confluent cells (Fig. 4e, f, respectively).
Fig. 2  Fzd5 expression is crucial for vascular formation in  vitro. 
a Representative fluorescent microscope images of GFP-labeled 
HUVECs (green) in co-culture with dsRED-labeled pericytes (red) 
in a 3D collagen matrix during vascular formation. Shown are the 
results at day 2 and 5 of non-transfected control, siSHAM, and siFzd5 
conditions. Scale bar in the left columns represents 1  mm. Scale 
bar in the right columns represents 350 µm. b Bar graphs show the 
quantified results of the co-culture assay. Shown are the total tubule 
length, and the number of endothelial junctions and tubules relative to 
the control conditions, both after 2 and 5 days. N = 4, *P < 0.05 com-
pared to control and siSHAM condition
◂
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Fzd5 knockdown induces the expression of several 
(anti‑) angiogenic factors
To further elucidate the anti-angiogenic phenotype observed 
after Fzd5 knockdown, expression levels of several impor-
tant regulators of angiogenesis were analyzed. In contrast to 
what was previously reported [17], our findings in HUVECs 
indicate that expression of tissue factor (TF) is not positively 
regulated by Fzd5 signaling, as Fzd5 knockdown did not 
attenuate TF expression. In fact, TF was slightly upregulated 
in Fzd5-silenced HUVECs compared to untreated control 
cells, yet was statistically equal to non-targeting siRNA-
treated HUVECs (Supplemental Fig. 2). Interestingly, vas-
cular endothelial growth Factor A (VEGFa) decoy recep-
tor Flt1, and the vascular destabilizing factor Angpt2 were 
significantly upregulated at both mRNA and protein level 
in HUVECs treated with Fzd5 siRNA when compared to 
untreated or non-targeting siRNA-treated HUVECs (Fig. 5a, 
c). Expression levels of VEGF receptor 2, VEGFa, as well as 
Angpt1 remained unaffected in the absence of Fzd5 (Supple-
mental Fig. 2). In line with previous findings of Lobov et al., 
combined addition of Flt1 and Angpt2 in the 3D co-culture 
Fig. 3  Endothelial knockdown of Fzd5 significantly inhibited EC 
migration and proliferation, but had no effect on apoptosis. a Rep-
resentative fluorescent microscope images of Calcein-AM-labeled 
HUVECs (green) in a plug-stopper-based migration assay. Shown are 
the results of 16 h of migration of non-transfected control, siSHAM, 
and siFzd5 conditions. Scale bar represents 500 µm. Open migration 
areas produced by the plug-stopper before initiation of the assay are 
indicated by dotted lines. b Bar graph shows the quantified results 
of migration assay. Shown are the percentages of surface area within 
the dotted circle covered by HUVECs after 16 h of migration. N = 4, 
*P < 0.05 compared to control and siSHAM condition. c ECs expan-
sion at 24, 48, and 72 h post seeding in similar densities, as quantified 
by flow cytometry. N = 3, *P < 0.05 compared to control and siSHAM 
condition (two-way ANOVA followed by Bonferroni post hoc test). 
d Representative histogram of flow cytometric analysis of PI-based 
DNA staining showing the distribution of cells over the cell cycle 
in the different groups at 48 h post-transfection. e Quantified results 
of cell cycle analysis. Percentage of cells in  G0/G1 phase is shown. 
N = 3, *P < 0.05 compared to control and siSHAM condition. f Quan-
tified results of TUNEL staining. Percentage TUNEL-positive cells 
of total number of cell is shown, 72  h post-transfection of control, 
siSHAM, and siFzd5 conditions. N = 3, no significance. g Representa-
tive fluorescent microscope images of DAPI-based nuclei staining in 
HUVECs (blue, upper row) and TUNEL staining of the same cells 
(red, lower row). Positive control was treated with DNAse solution. 
Scale bar represents 200 µm
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system completely attenuated endothelial tubule formation 
(Fig. 5d, e) [9].
Knockdown of a Fzd receptor can not only attenuate sig-
nal transduction, but due to impaired inhibitory crosstalk 
between the individual pathways, or via alternative receptor 
binding by the Wnt ligand can also have a stimulatory effect 
[18, 19]. Since Fzd5 knockdown had no effect on the canoni-
cal Wnt signaling pathway, the described non-canonical 
Wnt/Ca2+ and PCP pathways were studied for their potential 
role in the upregulation of Angpt2 and Flt1. Activation of the 
Wnt/Ca2+ pathway could induce Flt1 and Angpt2 transcrip-
tion, as stimulation of the Wnt/Ca2+ pathway leads to free 
 Ca2+-induced activation of Calcineurin, which in turn could 
promote NFAT-mediated transcription by dephosphorylating 
NFAT [6]. The mRNA expression level of Down Syndrome 
Critical Region 1 (DSCR1) was evaluated to assess the 
Fig. 4  Fzd5 knockdown did not affect the canonical Wnt signaling 
pathway in ECs. a Representative Western blot result of total levels 
of β-catenin, non-phospho-β-catenin, phospho-β-catenin (ser33/37/
thr41), and β-actin loading control, at different time points post-trans-
fection. b Quantified results of β-catenin Western blot. Shown are 
β-catenin levels relative to β-actin loading control. N = 3, no signifi-
cance. c Western blot result of total levels of β-catenin and phospho-
β-catenin in response to treatment with the phosphatase inhibitor 
Calyculin A (50 nM) with and without a 30 min pretreatment of the 
GSK3β inhibitor LiCl (20  mM). d QPCR analysis of the mRNA 
expression levels of β-catenin target genes Axin2, Cyclin D1 (Ccnd1), 
and C-myc in different conditions 72  h post-transfection. N = 4, no 
significance. e Immunofluorescent staining β-catenin (green), F-actin 
(red), and DAPI (blue) in confluent and sub-confluent f HUVECs 
after knockdown of Fzd5. N = 3
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potential link between Fzd5 knockdown and NFAT activa-
tion, as DSCR1 is a profound target gene of NFAT, involved 
in a feedback loop to fine-tune NFAT-mediated transcrip-
tion [20, 21]. However, no correlation between endothelial 
knockdown of Fzd5 and DSCR1 upregulation was observed 
(Fig. 6a). The involvement of NFAT-mediated transcription 
was also evaluated by pharmacological inhibition of the 
Wnt/Ca2+ signaling cascade using the Calcineurin inhibitor 
Cyclosporine A (CsA). The effectiveness of CsA (1 µM) 
was confirmed by its ability to inhibit calcium ionophore 
(A23187)-induced transcription of DSCR1 as a result of free 
 Ca2+-mediated NFAT activation in ECs (Fig. 6a). In line 
with the absence of DSCR1 upregulation in the Fzd5 knock-
down condition, the upregulation of Flt1 and Angpt2 could 
not be linked to an increase of NFAT-mediated transcription 
in the Fzd5 knockdown condition, as CsA stimulation failed 
to reduce Angpt2 and Flt1 upregulation in Fzd5-silenced 
cells (Fig. 6b).
Besides activation of the Wnt/Ca2+ pathway, the PCP 
pathway could also stimulate the expression of Flt1 and 
Fig. 5  Fzd5 knockdown led to increased expression of vascular 
regression-associated genes Flt1 and Angpt2. a QPCR results of 
expression levels of Angpt2 and Flt1 in different conditions 72  h 
post-transfection. N = 11, *P < 0.05 compared to control and siSHAM 
condition. b Representative Western blot results of Angpt2 expres-
sion levels in the different conditions 72 h post-transfection. N = 3. c 
Enzyme-linked immunosorbent assay-based quantification of secreted 
Flt1 levels in cultured endothelial medium 72  h post-transfection. 
N = 8, *P < 0.05 compared to control and siSHAM condition. d Rep-
resentative fluorescent microscope images of GFP-labeled HUVECs 
(green) in co-culture with dsRED-labeled pericytes (red) in a 3D col-
lagen matrix during vascular formation. Shown are the results at day 
5 of an untreated control, and after stimulation with PBS, Angpt2 
(1000  ng/ml), Flt1 (1000  ng/ml), and Angpt2 + Flt1 (1000  ng/ml 
both). Scale bar in the upper row represent 1 mm, in the bottom row 
350  µm. e Bar graphs show the quantified results of the co-culture 
assay. Shown are the total tubule length, and the number of endothe-
lial junctions and tubules after 5 days. N = 4, *P < 0.05 compared to 
control and siSHAM condition
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Angpt2 via activation of the Wnt/PCP signaling cascade 
linked to downstream JNK-induced transcriptional activa-
tion of c-JUN [22, 23]. Activation of JNK/c-JUN-mediated 
transcription involves phosphorylation of JNK, which was 
slightly increased both 48 and 72 h post-transfection (Fig. 6c, 
d). JNK-mediated phosphorylation of c-JUN, however, was 
not observed (Supplemental Fig. 4A, B). Since JNK is a 
kinase with a broad spectrum of downstream substrates [24], 
Fig. 6  Fzd5 knockdown led to increased expression of vascular 
regression-associated genes Flt1 and Angpt2, independent of the 
non-canonical Wnt/Ca2+ and PCP pathways. a QPCR results of 
expression levels of NFAT target gene Dscr1 in the different condi-
tions 72  h post-transfection and in response to ionophore A23187 
(10 µM)-induced  Ca2+ flux with and without NFAT inhibitor Cyclo-
sporin A (CsA) (1  µM). N = 5, *P < 0.05 compared to control and 
siSHAM condition, and DMSO-treated and CsA + A23187-treated 
ECs, respectively. b Angpt2 and Flt1 mRNA expression levels in 
HUVECs in response to CsA, supplemented 48  h post-transfection. 
N = 4, *P < 0.05 compared to control and siSHAM condition (two-
way ANOVA followed by Bonferroni post hoc test). c Representa-
tive Western blot of total JNK, phospho-JNK, and β-actin levels at 
different time points post-transfection. d Quantified results of JNK 
and phospho-JNK Western blot. Shown are individual (phospho) 
JNK isoform (p46 and p54) levels relative to β-actin loading control. 
N = 6, *P < 0.05 compared to control and siSHAM condition within 
one time comparison (24, 48 or 72 h). e Western blot of total JNK, 
phospho-JNK, and β-actin levels in response to different concentra-
tions of JNK inhibitor SP600125 after 1 h. f QPCR analysis showing 
the effect of SP600125, supplemented 48 h post-transfection, on Flt1 
and Angpt2 mRNA levels in the different conditions. N = 4, *P < 0.05 
compared to control and siSHAM condition, #P < 0.05 as indicated in 
graph (two-way ANOVA followed by Bonferroni post hoc test)
 Angiogenesis
1 3
the JNK inhibitor SP600125 was used to block activation 
of JNK to define whether the enhanced phosphorylation of 
JNK played a role in the upregulation of Flt1 and Angpt2. 
The effectiveness of SP600125 (20 µM) was confirmed by 
its ability to inhibit JNK phosphorylation in ECs (Fig. 6e). 
Treatment of HUVECs with SP600125 did not diminish 
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Fzd5 silencing-induced upregulation of Flt1 and Angpt2 
(Fig. 6f). In contrast, SP600125 treatment rather induced a 
general upregulation of Angpt2, indicating that activation 
of JNK was not causally related to the Fzd5 knockdown-
mediated upregulation of both genes.
Angpt2 and Flt1 upregulation is mediated via PKC 
and Ets1
Previously, it was demonstrated that Wnt signal transduction 
also involves PKC [25–27]. PKCs are part of a kinase fam-
ily with a diverse range of potential downstream targets. To 
verify whether Fzd5 knockdown-induced upregulation of 
Flt1 and Angpt2 depended on activation of PKC, HUVECs 
were treated with the PKC inhibitor Staurosporine in the 
concentration range of 5–20 nM, as not all different PKC 
family members are equally inhibited at similar concentra-
tions. Interestingly, both Angpt2 and Flt1 overexpression 
induced by Fzd5 knockdown were dose-dependently reduced 
by PKC inhibition compared to control and siSHAM condi-
tion (Supplemental Fig. 5A). Since HUVECs express mul-
tiple PKC isoforms [28, 29], PKC expression was knocked 
down by siRNA to interrogate which isoform mediated the 
observed upregulation of Angpt2 and Flt1. Individual PKC 
isoform knockdown only had a minor effect on the Fzd5 
knockdown-induced overexpression of the anti-angiogenic 
factors, whereas combined knockdown of the novel PKCs 
(nPKCs) completely attenuated the upregulation of Angpt2 
and Flt1 (Fig. 7a, Supplemental Fig. 5B).
PKC signaling can induce elevated synthesis of the 
transcription factor Protein C-ets1 (Ets1) [30, 31], which 
has binding sites in the promoter regions of both Angpt2 
and Flt1 [32, 33]. Ets1 was significantly upregulated in 
the absence of Fzd5, which was orchestrated by PKC 
(Supplemental Fig. 5C). Involvement of Ets1 in transcrip-
tional regulation of Angpt2 and Flt1 was evaluated in the 
Fzd5 knockdown condition using a double knockdown 
of both Fzd5 and Ets1. Knockdown of Ets1 alone had no 
effect on the expression of Flt1 and Angpt2 compared to 
control and siSHAM condition, indicating no active tran-
scription regulation of these two genes by Ets1 in control 
conditions. However, knockdown of Ets1 in Fzd5-silenced 
HUVECs fully inhibited upregulation of Angpt2 and par-
tially inhibited the upregulation of Flt1 when compared to 
Fzd5-silenced controls (Fig. 7b). The involvement of Ets1-
induced transcription was further substantiated by a similar 
Ets1-dependent upregulation of Matrix metalloproteinase 1 
(MMP1), a verified endothelial target gene of Ets1 (Supple-
mental Fig. 6A, B) [34]. To evaluate if the anti-angiogenic 
phenotype of Fzd5 silencing observed in the 3D angiogen-
esis co-culture assay was mediated via this pathway, Ets1 
was silenced in GFP-labeled HUVECs. Analysis of the 3D 
co-culture results demonstrated that inhibition of Ets1 in the 
Fzd5 knockdown condition partly rescued the Fzd5 knock-
down-mediated reduction of endothelial tubule formation 
(Fig. 7c, d).
Discussion
The main findings of the current study are (1) endothelial 
Fzd5 expression is essential for vascular formation, as shown 
in a 3D co-culture assay. (2) Fzd5 silencing inhibits EC pro-
liferation and migration. (3) Endothelial loss of Fzd5 expres-
sion does not interfere with endogenous canonical Wnt sign-
aling. (4) Fzd5 knockdown leads to increased expression 
of vascular regression-associated factors Flt1 and Angpt2, 
independent of both the non-canonical Wnt/Ca2+-mediated 
activation of NFAT and PCP-mediated activation JNK. (5) 
Inhibition of nPKC signaling, as well as knockdown of the 
PKC target Ets1 suppressed the upregulation of Flt1 and 
Angpt2 in the absence of Fzd5. The Ets1 knockdown inter-
vention also partially rescued the Fzd5 knockdown-induced 
inhibitory effect on new vessel formation.
Previously, it was reported that Fzd5 is indispensable for 
murine embryogenesis [5]. Fzd5 knockout embryos died in 
utero from severe defects in yolk sac and placenta vasculari-
zation. Using trophoblast-specific Fzd5 knockout mice, Lu 
et al. reported that the observed phenotype in the Fzd5 full 
knockout placenta was partly initiated by a defect in chori-
onic branching morphogenesis [35]. As defective branch-
ing morphogenesis of the chorion of these mice resulted in 
a smaller placental labyrinth layer compared to wild-type 
littermates, it remained difficult to distinguish whether the 
placental defects observed in the Fzd5 full knockout mice 
were indeed vascular related, or the outcome of propor-
tional growth limitations resulting from the reduced villous 
Fig. 7  Fzd5 knockdown-induced upregulation of Angpt2 and 
Flt1 expression is mediated via enhanced PKC and Ets1 signal-
ing. a QPCR results showing expression levels of Angpt2 and Flt1 
in HUVECs after knockdown of Fzd5 alone, in combination with 
knockdown of different PKC isoforms, and in combination with 
knockdown of all novel PKC isoforms (PKCδ,ε,η), 48  h post-trans-
fection. N = 4, *P < 0.05 compared to control and siSHAM condi-
tion, #P < 0.05 as indicated in graph. b QPCR results of Angpt2 and 
Flt1 expression in HUVECs, 72  h post-transfection, with and with-
out knockdown of transcription factor Ets1, a downstream target of 
PKC. N = 4, *P < 0.05 compared to control and siSHAM condition, 
#P < 0.05 as indicated in graph. c Representative fluorescent micro-
scope images of GFP-labeled HUVECs (green) in co-culture with 
dsRED-labeled pericytes (red) in a 3D collagen matrix during vas-
cular formation. Shown are the results at day 5 of non-transfected 
control, siSHAM, siFzd5, siEts1 and the combined knockdown of 
Fzd5 and Ets1. Scale bar in the upper row represents 1  mm, in the 
bottom row 350 µm. d Bar graphs show the quantified results of the 
co-culture assay. Shown are the total tubule length, and the number 
of endothelial junctions and tubules after 5 days. N = 6, *P < 0.05 
compared to control and siSHAM condition, #P < 0.05 as indicated in 
graph
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volume. In our study, we demonstrated that endothelial 
knockdown of Fzd5 in vitro leads to a severe reduction in 
vascular tubule formation in a 3D co-culture model, thereby 
providing evidence for the direct role of Fzd5 in new vessel 
growth.
The most detailed described Fzd/Wnt signaling cascade 
is the canonical or β-catenin-dependent pathway. Without 
stimulation of the canonical pathway, β-catenin is degraded 
by a destruction complex consisting of Axin, Glycogen Syn-
thase Kinase 3ß, Adenomatous Polyposis Coli, and Casein 
Kinase 1α. Upon binding of Wnt ligands to a Fzd receptor 
in the presence of the co-receptor Lrp5 or Lrp6, a conforma-
tion change in Lrp extracts Axin away from the destruction 
complex, leading to an increase in intracellular β-catenin 
levels. When translocated into the nucleus, β-catenin binds 
to the TCF/Lef complex and promotes the expression of 
β-catenin target genes [6–8]. Knockdown of a Fzd receptor 
could both have an inhibiting effect on this pathway, due 
to a reduction in receptors capable of transducing a signal 
for downstream signaling cascade activation, and an acti-
vating effect, either due to impaired inhibitory crosstalk 
between the individual pathways or via alternative receptor 
binding by the Wnt ligand [18, 19]. Involvement of Fzd5 
in this canonical pathway appears to be tissue dependent. 
Steinhart et al. recently demonstrated that canonical Wnt 
signaling via Fzd5 was involved in pancreatic tumor growth 
and Caricasole et al. reported enhanced β-catenin-mediated 
signaling upon Wnt7a interaction with both Fzd5 and Lrp6 
in the rat pheochromocytoma cell line PC12 [36, 37]. In 
the mouse optic vesicle, however, no evidence suggests that 
Fzd5 activates or suppresses canonical Wnt signaling [38, 
39]. Our analysis of endogenous canonical Fzd/Wnt sign-
aling suggests that Fzd5 is not involved in Wnt β-catenin 
signaling in ECs.
In contrast to the β-catenin target genes, expression lev-
els of Angpt2 and Flt1 were significantly upregulated in 
HUVECs with suppressed Fzd5 expression. Angpt2 by itself 
is known to have a positive effect on neovessel formation, as 
it is involved in pericyte detachment and destabilization of 
the endothelium to potentiate the actions of pro-angiogenic 
factors [40, 41]. However, in the absence of VEGFa, or in 
the presence of an increased expression of Flt1, a decoy 
receptor for VEGFa, Angpt2 is known to induce vascular 
regression [9–11]. Both Angpt2 and Flt1 are potential down-
stream target genes of the non-canonical Fzd/Wnt signal-
ing pathways. Upon stimulation of the Fzd/Wnt/Ca2+ path-
way, activation of phospholipase C leads to cleavage of the 
membrane component PIP2 into DAG and IP3. When IP3 
binds to its receptor on the endoplasmic reticulum,  Ca2+ is 
released in the cytosol, activating the transcription factor 
NFAT via Calcineurin [6]. In recent studies, Flt1 and Angpt2 
were shown to be transcriptional targets of NFAT [42, 43]. 
Like Angpt2 and Flt1, the endogenous NFAT inhibitor 
DSCR1 is also a verified target of the transcription factor 
NFAT [20, 21], yet our data showed that the expression level 
of DSCR1 remained stable after knockdown of Fzd5. More 
important, our experiments demonstrated that inhibition of 
NFAT activation with CsA after endothelial knockdown of 
Fzd5 did not inhibit the upregulation of Angpt2 and Flt1, 
suggesting that the enhanced transcription of these anti-
angiogenic factors was not mediated by enhanced activity 
of NFAT. Alternatively, stimulation of the Fzd/Wnt/PCP 
pathway can also induce the transcription of Flt1 and Angpt2 
via GTPase-mediated activation of JNK, which eventually 
activates c-JUN-based transcription [6]. Multiple studies 
provided evidence for transcriptional regulation of Flt1 and 
Angpt2 either by c-JUN alone, or by the transcription com-
plex AP-1 involving c-JUN [22, 23]. Our data indicated that 
Fzd5 knockdown led to an increase in JNK phosphorylation, 
but no increase in c-JUN phosphorylation was observed. In 
addition, inhibition of JNK activity with SP600125 ruled 
out the involvement of the PCP-JNK signal transduction 
axis as causal factor for the enhanced expression of vascular 
regression-associated factors Angpt2 and Flt1 in ECs with 
Fzd5 knockdown, as upregulation of these factors remained 
evident. In future studies, however, it remains of interest to 
further dissect the relevance of this altered JNK signaling 
in the absence of Fzd5.
Multiple reports have previously suggested a role for PKC 
involvement in Fzd/Wnt signaling [25–27]. Staurosporine, 
as well as siRNA-mediated knockdown of nPKCs inhib-
ited the upregulation of Angpt2 and Flt1 in HUVECs with 
suppressed expression of Fzd5, indicating the involvement 
of PKC signaling in the transcriptional regulation of these 
genes in Fzd5-silenced ECs. The promoter regions of both 
Angpt2 and Flt1 contain binding sites of the transcription 
factor Ets1 [32, 33], which was shown by our data to be PKC 
dependently upregulated in the absence of Fzd5. Our results 
demonstrate the involvement of enhanced Ets1-mediated 
transcription of these two genes in Fzd5-silenced ECs, as 
Ets1 knockdown resulted in a marked repression of Angpt2 
and Flt1 expression levels. Another validated endothelial 
target of PKC/Ets1-mediated transcription, MMP1, which 
like Angpt2 and Flt1 was previously shown to be involved 
in vascular regression [34], was also upregulated via Ets1 
in the absence of Fzd5. The involvement of Ets1 was fur-
ther validated using the 3D co-culture model, in which Ets1 
knockdown in Fzd5-silenced ECs partially rescued the 
inhibitory effect on new vessel formation that was observed 
in Fzd5-silenced conditions. These results indicate a repress-
ing function on PKC/Ets1 signaling by Fzd5 in ECs, leading 
to reduced expression of vascular regression-associated fac-
tors Angpt2 and Flt1.
In this study, the effect of Fzd5 knockdown on the differ-
ent Fzd/Wnt signaling routes was studied without the addi-
tion of exogenous Wnt factors. HUVECs secrete Wnt factors 
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themselves, among which the typical canonical factor Wnt3 
and non-canonical factor Wnt5a. Knockdown of endothelial 
Fzd5 led to functional defects, as well as differential expres-
sion of important genes in the angiogenic process, indicat-
ing that lack of Fzd5 interferes with endogenous Fzd/Wnt 
signaling. The nature of this endogenous signaling in the 
absence of Fzd5 was shaped by the finding that combined 
knockdown of Fzd5 and endogenous Wnt5a significantly 
suppressed Angpt2 and Flt1 upregulation (Supplemental 
Fig. 7). It was previously demonstrated that Wnt factors 
induce signaling to a variety of Fzd and non-Fzd receptors, 
and that binding selectivity is receptor context dependent 
[13, 44]. As suppression of endogenous Wnt5a signaling 
partially rescued the Fzd5 knockdown-induced upregula-
tion of Angpt2 and Flt1, our data suggest that endothelial 
knockdown of Fzd5 provokes its ligand Wnt5a to signal via 
an alternative receptor, thereby triggering the activation 
of the observed PKC/Ets1-mediated transcription (Fig. 8). 
Although our experiments demonstrate that this alternative 
signaling route via PKC and Ets1 plays an important role 
in the poor angiogenic phenotype in the absence of Fzd5, 
the relative contribution of suppressed Fzd5 signaling itself 
to this phenomenon is yet to be determined. Future studies 
should also aim to identify the unknown alternative Wnt5a 
receptor.
The aim of this study was to explore the involvement 
of Fzd5 in vascular and perivascular biology, which might 
eventually serve as a foundation for future therapeutic 
strategies, e.g., in modulating tumor vasculature. A recent 
genome-wide CRISPR-Cas9 study demonstrated that Fzd5 
is a potential druggable target in specific subtypes of pan-
creatic tumors [36]. Signaling via Fzd5 in these tumor cells 
was shown to be crucial in β-catenin-mediated proliferation 
and treatment of these pancreatic adenocarcinoma cells with 
Fzd5 antibodies led to inhibited cell growth, both in vitro 
and in xenograft models in vivo. Although these pancreatic 
adenocarcinoma tumors are not excessively vascularized, 
they were previously shown to depend on angiogenesis for 
growth [45, 46]. Our data demonstrate the importance of 
Fzd5 in ECs during angiogenesis and might imply that tar-
geting the Fzd5 in these types of tumors not only affects 
the pancreatic adenocarcinoma cells, but could in addi-
tion potentially result in beneficial suppression of tumor 
vascularization.
In conclusion, the current study provides evidence for an 
important role of endothelial Fzd5 in angiogenesis, thereby 
providing novel insights in the molecular mechanism causal 
to the poor angiogenic phenotype in the absence of this 
receptor.
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Fig. 8  Schematic representation of the proposed model of signal-
ing via Fzd5 in ECs. Our data provide evidence for a new proposed 
model of signaling in ECs in the absence of Fzd5. Knockdown of this 
receptor provokes its ligand Wnt5a to signal via an alternative recep-
tor, thereby triggering the activation of nPKC/Ets1-mediated tran-
scription of vascular regression-associated factors, among which Flt1 
and Angpt2
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